Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quanex Building Products (NX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Quanex Building Products (NX) over the last 17 years, with Q3 2025 value amounting to $66.3 million.

  • Quanex Building Products' Cash & Equivalents fell 2947.24% to $66.3 million in Q3 2025 from the same period last year, while for Jul 2025 it was $66.3 million, marking a year-over-year decrease of 2947.24%. This contributed to the annual value of $97.7 million for FY2024, which is 6715.81% up from last year.
  • Latest data reveals that Quanex Building Products reported Cash & Equivalents of $66.3 million as of Q3 2025, which was down 2947.24% from $62.6 million recorded in Q2 2025.
  • Over the past 5 years, Quanex Building Products' Cash & Equivalents peaked at $97.7 million during Q4 2024, and registered a low of $31.7 million during Q1 2022.
  • In the last 5 years, Quanex Building Products' Cash & Equivalents had a median value of $50.0 million in 2025 and averaged $54.8 million.
  • Examining YoY changes over the last 5 years, Quanex Building Products' Cash & Equivalents showed a top increase of 8787.75% in 2021 and a maximum decrease of 3862.08% in 2021.
  • Quanex Building Products' Cash & Equivalents (Quarter) stood at $40.1 million in 2021, then skyrocketed by 37.52% to $55.1 million in 2022, then rose by 6.14% to $58.5 million in 2023, then soared by 67.16% to $97.7 million in 2024, then plummeted by 32.2% to $66.3 million in 2025.
  • Its Cash & Equivalents stands at $66.3 million for Q3 2025, versus $62.6 million for Q2 2025 and $50.0 million for Q1 2025.